← FDA Drug Approvals (Drugs@FDA)
SKYRIZI
BLA · Biologics License Application · Sponsor: ABBVIE INC · Approved 2022-06-16
Drug application
- FDA Application #
BLA761262- Application type
- Biologics License Application
- Brand name
- SKYRIZI
- Generic name
- RISANKIZUMAB-RZAA
- Active ingredients
- RISANKIZUMAB-RZAA
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ABBVIE INC
- Manufacturer
- AbbVie Inc.
- First approval
- 2022-06-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown